Verition Fund Management’s Esperion Therapeutics ESPR Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q2
$13.8K Sell
14,050
-16,460
-54% -$16.2K ﹤0.01% 2833
2025
Q1
$43.9K Buy
30,510
+16,460
+117% +$23.7K ﹤0.01% 2535
2024
Q4
$30.9K Hold
14,050
﹤0.01% 2485
2024
Q3
$23.2K Hold
14,050
﹤0.01% 2362
2024
Q2
$31.2K Hold
14,050
﹤0.01% 2185
2024
Q1
$37.7K Hold
14,050
﹤0.01% 2040
2023
Q4
$42K Sell
14,050
-75,000
-84% -$224K ﹤0.01% 1741
2023
Q3
$87.3K Sell
89,050
-61,645
-41% -$60.4K ﹤0.01% 1779
2023
Q2
$209K Buy
150,695
+96,289
+177% +$134K ﹤0.01% 1560
2023
Q1
$86.5K Buy
54,406
+39,156
+257% +$62.3K ﹤0.01% 1752
2022
Q4
$95K Sell
15,250
-18,670
-55% -$116K ﹤0.01% 1447
2022
Q3
$227K Buy
33,920
+17,120
+102% +$115K ﹤0.01% 1851
2022
Q2
$107K Buy
+16,800
New +$107K ﹤0.01% 1979
2019
Q3
Sell
-4,833
Closed -$225K 1010
2019
Q2
$225K Buy
+4,833
New +$225K 0.01% 847